MegaMD Statistics

Total Valuation

MegaMD has a market cap or net worth of KRW 46.80 billion. The enterprise value is 11.28 billion.

Market Cap	46.80B
Enterprise Value	11.28B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

MegaMD has 22.07 million shares outstanding. The number of shares has increased by 0.34% in one year.

Current Share Class	n/a
Shares Outstanding	22.07M
Shares Change (YoY)	+0.34%
Shares Change (QoQ)	+0.90%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	4.23%
Float	10.55M

Valuation Ratios

The trailing PE ratio is 12.40.

PE Ratio	12.40
Forward PE	n/a
PS Ratio	1.29
PB Ratio	0.71
P/TBV Ratio	0.76
P/FCF Ratio	5.77
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.63, with an EV/FCF ratio of 1.39.

EV / Earnings	2.98
EV / Sales	0.31
EV / EBITDA	1.63
EV / EBIT	6.24
EV / FCF	1.39

Financial Position

The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.07.

Current Ratio	2.30
Quick Ratio	2.22
Debt / Equity	0.07
Debt / EBITDA	0.62
Debt / FCF	0.57
Interest Coverage	9.62

Financial Efficiency

Return on equity (ROE) is 5.91% and return on invested capital (ROIC) is 2.10%.

Return on Equity (ROE)	5.91%
Return on Assets (ROA)	1.68%
Return on Invested Capital (ROIC)	2.10%
Return on Capital Employed (ROCE)	3.38%
Revenue Per Employee	233.92M
Profits Per Employee	24.25M
Employee Count	156
Asset Turnover	0.42
Inventory Turnover	25.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.36% in the last 52 weeks. The beta is 0.48, so MegaMD's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-24.36%
50-Day Moving Average	2,150.00
200-Day Moving Average	2,138.05
Relative Strength Index (RSI)	48.80
Average Volume (20 Days)	75,918

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MegaMD had revenue of KRW 36.49 billion and earned 3.78 billion in profits. Earnings per share was 171.00.

Revenue	36.49B
Gross Profit	21.85B
Operating Income	2.31B
Pretax Income	4.81B
Net Income	3.78B
EBITDA	7.41B
EBIT	2.31B
Earnings Per Share (EPS)	171.00

Full Income Statement

Balance Sheet

The company has 40.15 billion in cash and 4.63 billion in debt, giving a net cash position of 35.52 billion or 1,608.98 per share.

Cash & Cash Equivalents	40.15B
Total Debt	4.63B
Net Cash	35.52B
Net Cash Per Share	1,608.98
Equity (Book Value)	65.78B
Book Value Per Share	2,979.78
Working Capital	24.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.39 billion and capital expenditures -281.57 million, giving a free cash flow of 8.11 billion.

Operating Cash Flow	8.39B
Capital Expenditures	-281.57M
Free Cash Flow	8.11B
FCF Per Share	367.18

Full Cash Flow Statement

Margins

Gross margin is 59.89%, with operating and profit margins of 6.34% and 10.37%.

Gross Margin	59.89%
Operating Margin	6.34%
Pretax Margin	13.18%
Profit Margin	10.37%
EBITDA Margin	20.30%
EBIT Margin	6.34%
FCF Margin	22.21%

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.89%.

Dividend Per Share	60.00
Dividend Yield	2.89%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.34%
Shareholder Yield	2.55%
Earnings Yield	8.08%
FCF Yield	17.32%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MegaMD has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	n/a